Malin E Winerdal
Overview
Explore the profile of Malin E Winerdal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
391
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bergman E, Hartana C, Johansson M, Linton L, Berglund S, Hyllienmark M, et al.
Clin Epigenetics
. 2018 Aug;
10(1):102.
PMID: 30075815
Background: Urinary bladder cancer is a common malignancy worldwide. Environmental factors and chronic inflammation are correlated with the disease risk. Diagnosis is performed by transurethral resection of the bladder, and...
2.
Krantz D, Hartana C, Winerdal M, Johansson M, Alamdari F, Jakubczyk T, et al.
Eur Urol
. 2018 Jul;
74(6):688-692.
PMID: 30025882
Evidence indicates that neoadjuvant chemotherapy (NAC) may promote antitumour immune responses by activating T cells. The tumour-draining sentinel node (SN) is a key site to study tumour-specific T cell activation,...
3.
Hartana C, Bergman E, Zirakzadeh A, Krantz D, Winerdal M, Winerdal M, et al.
PLoS One
. 2018 Jul;
13(7):e0200079.
PMID: 29966014
The immune system plays a significant role in urothelial bladder cancer (UBC) progression, with CD8+ T cells being capable to directly kill tumor cells using perforin and granzymes. However, tumors...
4.
Winerdal M, Krantz D, Hartana C, Zirakzadeh A, Linton L, Bergman E, et al.
Cancer Immunol Res
. 2018 Mar;
6(5):528-538.
PMID: 29588320
Regulatory T cells (Treg) have long been considered one-sided suppressors of antitumor immune responses and hence associated with poor patient outcome in cancer. However, evidence is mounting of a paradoxical...
5.
Winerdal M, Urmaliya V, Winerdal M, Fredholm B, Winqvist O, Aden U
PLoS One
. 2017 Jan;
12(1):e0170545.
PMID: 28129361
In this randomized blinded study, we investigated caffeine 5 mg/kg treatment given directly after neonatal brain hypoxia ischemia. Brain morphology, behavior and key brain infiltrating immune populations were examined. Caffeine...
6.
Zirakzadeh A, Kinn J, Krantz D, Rosenblatt R, Winerdal M, Hu J, et al.
Clin Immunol
. 2016 Dec;
176:63-70.
PMID: 28025135
Cancer is currently treated by a combination of therapies, including chemotherapy which is believed to suppress the immune system. Combination of immunotherapy and chemotherapy correlates with improved survival but needs...
7.
Yang T, Zollbrecht C, Winerdal M, Zhuge Z, Zhang X, Terrando N, et al.
J Am Heart Assoc
. 2016 Jul;
5(7).
PMID: 27431647
Background: Early-life reduction in nephron number (uninephrectomy [UNX]) and chronic high salt (HS) intake increase the risk of hypertension and chronic kidney disease. Adenosine signaling via its different receptors has...
8.
Winerdal M, Winerdal M, Wang Y, Fredholm B, Winqvist O, Aden U
Purinergic Signal
. 2015 Nov;
12(1):89-101.
PMID: 26608888
Neonatal brain hypoxic ischemia (HI) often results in long-term motor and cognitive impairments. Post-ischemic inflammation greatly effects outcome and adenosine receptor signaling modulates both HI and immune cell function. Here,...
9.
Hu J, Lou D, Carow B, Winerdal M, Rottenberg M, Wikstrom A, et al.
PLoS One
. 2012 Feb;
7(1):e30166.
PMID: 22291912
Recent studies suggest that SOCS2 is involved in the regulation of TLR signaling. In this study, we found that the expression of SOCS2 is regulated in human monocyte-derived DC by...
10.
Winerdal M, Marits P, Winerdal M, Hasan M, Rosenblatt R, Tolf A, et al.
BJU Int
. 2011 Jan;
108(10):1672-8.
PMID: 21244603
Objective: To investigate the possible impact of FOXP3 expression in T-cells, as well as in tumour cells, on long-term survival in patients with urinary bladder cancer (UBC) invading muscle. Patients...